您的当前位置:首页 > 行业数据 > 图16APG-115单药治疗进展性涎腺癌患者,包括腺样囊性癌(ACC)患者展现了良好的抗肿瘤活性及耐受性
图片属性
图片格式:PNG 图片大小:550KB 图片尺寸:2389*899
同报告图片
 / 4
图16APG-115单药治疗进展性涎腺癌患者,包括腺样囊性癌(ACC)患者展现了良好的抗肿瘤活性及耐受性_第1页
fCDmsrvnlpfml7bpl7QgfCBOPTI1IHwg5rK755aX5pe26Ze077yI5pyI77yJIHwgTj03IHwg5rK755aX5pe26Ze077yI5pyI77yJIHwKfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfAp8IFBSIHwgNCAoMTYlKSB8IDExLjcgfCAtIHwgLSB8CnwgU0QgfCAyMCAoODAlKSB8IDguMSB8IDYuMCB8IDUuMSB8CnwgUEQgfCAxICg0JSkgfCAtIHwgMS4wIHwgLSB8CgoqKui1hOaWmeadpea6kCoqOiBOQ0NO5oyH5Y2XLCBDU0NP5oyH5Y2XLCBIVEk=
图16APG-115单药治疗进展性涎腺癌患者,包括腺样囊性癌(ACC)患者展现了良好的抗肿瘤活性及耐受性_第2页
图16APG-115单药治疗进展性涎腺癌患者,包括腺样囊性癌(ACC)患者展现了良好的抗肿瘤活性及耐受性_第3页
图16APG-115单药治疗进展性涎腺癌患者,包括腺样囊性癌(ACC)患者展现了良好的抗肿瘤活性及耐受性_第4页
图16APG-115单药治疗进展性涎腺癌患者,包括腺样囊性癌(ACC)患者展现了良好的抗肿瘤活性及耐受性_第5页
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
所属报告: 亚盛医药-港股公司首次覆盖报告:厚积薄发逐步迈向全球化Biopharma-241010(37页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠